Best Oral GLP-1 Tablet & ODT Providers in 2026 — Ranked & Reviewed

Most compounded GLP-1 providers ship injectable vials, but a growing minority offer oral formulations — sublingual tablets, oral dissolving tablets (ODT), or other non-injectable delivery. The clinical evidence for oral compounded GLP-1s is weaker than for the FDA-approved injectable equivalents (no STEP-or-SURMOUNT-equivalent randomized trials of oral compounded semaglutide or tirzepatide), and the only FDA-approved oral GLP-1 for weight loss is Lilly's Foundayo (orforglipron), which is a completely different small-molecule chemistry. That said, ODTs and oral tablets are a reasonable option for needle-averse patients willing to accept the weaker evidence base. Below we rank every provider in our directory offering an oral compounded GLP-1 alongside or instead of injectable versions, with explicit notes on form factor and evidence quality.

Lowest verified price: $7.29/mo106 providers compared

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

106 oral glp-1 tablet & odt providers compared · independently scored against our six-factor methodology.

Quick Picks: Top 5

#ProviderScore
1Amazon One MedicalVisit
2LillyDirect FoundayoVisit
3ShedRxVisit
4Strut HealthVisit
5Calibrate HealthVisit

Compare the top providers at a glance

Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.

  • ★ Editor's Pick
    Amazon One Medical

    the most authoritative brand-name GLP-1 channel, with same-day delivery

    From /mo
    $149
    Coverage
    50 states
    Medications
    Orforglipron
    Visit →
  • Nationwide Coverage
    LillyDirect Foundayo

    the cheapest legal brand-name GLP-1

    From /mo
    $149
    Scales with dose
    Coverage
    50 states
    Medications
    Orforglipron
    Visit →
  • ShedRx

    mainstream telehealth GLP-1 access

    From /mo
    $149
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatideOrforglipron
    Visit →
  • Strut Health

    oral-lozenge compounded GLP-1 access

    From /mo
    $99
    Coverage
    49 states
    Medications
    SemaglutideTirzepatide
    Visit →
  • Best Care Team
    Calibrate Health

    year-long coaching wrap around insured branded GLP-1s

    From /mo
    $199
    Coverage
    50 states
    Medications
    Semaglutide
    Visit →
  • YourHealthRx

    Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up

    From /mo
    $170
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
    Visit →
  • GoodRx

    self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies

    From /mo
    $149
    Scales with dose
    Coverage
    50 states
    Medications
    OrforglipronTirzepatide
    Visit →
  • Best Budget
    Embody

    low flat-rate compounded GLP-1 pricing at every dose

    From /mo
    $79
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
    Visit →
6scored dimensions
106oral glp-1 tablet & odt providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

Detailed Reviews

1

Amazon One Medical

Best for: the most authoritative brand-name GLP-1 channel, with same-day delivery

8.5

Amazon One Medical is the unified Amazon GLP-1 channel — One Medical clinicians prescribe FDA-approved Wegovy, Zepbound, and Foundayo (no compounded products), and Amazon Pharmacy fulfills with same-day delivery across roughly 3,000 US cities plus pickup kiosks at select One Medical locations. No prior membership required; insurance and cash pay both accepted. Foundayo launched at $25/month with insurance and the Lilly Savings Card, or $149/month cash pay.

Score Breakdown

Value25%
8.5
Effectiveness25%
8.5
User Experience15%
8
Trust & Safety15%
8.8
Accessibility10%
9.5
Support10%
8

Pros

  • ✓As low as $1/day ($25/month) for brand-name Foundayo with insurance and the auto-applied Lilly coupon
  • ✓Same-day delivery in nearly 3,000 US cities at launch, expanding to 4,500 by end of 2026
  • ✓In-office pharmacist kiosks at select One Medical clinics let you walk out with Foundayo in hand
  • ✓Cash-pay $5/day ($149/month) is competitive for the same FDA-approved brand-name product
  • ✓Real-time availability, transparent pricing, and automatic manufacturer coupon at checkout
  • ✓Delivering GLP-1 medications since 2021 — track record on cold-chain logistics

Cons

  • ✗Headline $25/month needs both insurance and the Lilly Savings Card — uninsured pay $149/month
  • ✗Same-day delivery is geographically gated; outside major cities it drops to next-day or slower
  • ✗Pricing is set by manufacturer savings programs and can change at any time
  • ✗No compounded options — brand-name only (Foundayo, Wegovy, Zepbound)
  • ✗Wegovy/Zepbound pricing isn't shown upfront — depends on insurance at the prescribing visit
  • ✗Copays and deductibles still apply to the clinical visit
Starting from $25/moRead full review →
Visit Amazon One Medical →
2

LillyDirect Foundayo

Best for: the cheapest legal brand-name GLP-1

8.1

Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss. With the Lilly Savings Card, commercially insured patients pay $25/month; cash-pay patients pay $149-$299/month depending on labeled dose. Requires a valid US prescription from any licensed prescriber.

Score Breakdown

Value25%
9
Effectiveness25%
7
User Experience15%
7.5
Trust & Safety15%
9.3
Accessibility10%
9
Support10%
6.5

Pros

  • ✓Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • ✓Direct from manufacturer — no compounding, no third-party reseller
  • ✓Daily oral pill, no injections, no refrigeration
  • ✓Available in all 50 states

Cons

  • ✗Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • ✗Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • ✗$25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • ✗Strict empty-stomach 30-minute window may be hard for some patients to follow
Starting from $25/moRead full review →
Visit LillyDirect Foundayo →
3

ShedRx

Verified partner

Best for: mainstream telehealth GLP-1 access

8.0

Telehealth provider offering compounded GLP-1 medications in injectable, lozenge, and drop formats.

Score Breakdown

Value25%
7.5
Effectiveness25%
9
User Experience15%
8
Trust & Safety15%
7.3
Accessibility10%
7.5
Support10%
8

Pros

  • ✓Both semaglutide and tirzepatide available
  • ✓Compounded GLP-1 access
  • ✓Multiple administration formats

Cons

  • ✗Limited public information on program details
Starting from $149/moRead full review →
Visit ShedRx →
4

Strut Health

Verified partner

Best for: oral-lozenge compounded GLP-1 access

8.0

Strut Health offers LegitScript + ACHC-accredited compounded semaglutide and tirzepatide in both injectable and oral lozenge formats, shipping to 49 states. Board-certified US physicians handle prescribing with free unlimited follow-up messaging, but eligibility is gated behind a 'medical necessity' clinician determination that isn't publicly defined.

Score Breakdown

Value25%
8.5
Effectiveness25%
8
User Experience15%
8
Trust & Safety15%
7.3
Accessibility10%
8
Support10%
8

Pros

  • ✓Both LegitScript and ACHC accredited — pharmacy oversight most compounded GLP-1 providers don't carry
  • ✓Oral lozenge option for semaglutide ($99/mo) and tirzepatide ($199/mo) — an injection-free alternative
  • ✓Auto-refill pricing saves 13–21% vs one-off orders
  • ✓Free unlimited follow-up messaging with board-certified US physicians
  • ✓Ships to 49 states (only Arkansas excluded)

Cons

  • ✗Requires a "medical necessity" review, but the criteria aren't published — you can't self-screen before paying for a consult
  • ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • ✗Pharmacy partners aren't named — you can't check the compounding source
  • ✗No insurance accepted — cash pay only
  • ✗Phone consultation requirement varies by state
Starting from $99/moRead full review →
Visit Strut Health →
5

Calibrate Health

Best for: year-long coaching wrap around insured branded GLP-1s

7.9

Calibrate Health is a year-long metabolic-reset program pairing branded GLP-1 medication (Wegovy, Ozempic, Zepbound, or Foundayo) with 1:1 video coaching and dietitian support — a deeper clinical wrap than transactional telehealth. It's branded-only, with a money-back guarantee tied to outcomes. The $199/month program fee runs separately from medication, which can drop to about $25/month with insurance and a savings card.

Score Breakdown

Value25%
6.5
Effectiveness25%
9
User Experience15%
7.5
Trust & Safety15%
8.3
Accessibility10%
8
Support10%
9

Pros

  • ✓Year-long program with 1:1 video coaching, dietitian support, and a behavior-change curriculum — deeper than transactional telehealth
  • ✓$199/month program fee is competitive; medication co-pay can drop to ~$25/month with insurance and a manufacturer savings card
  • ✓Branded GLP-1s only (Wegovy, Ozempic, Zepbound, Foundayo) — no compounded products
  • ✓Insurance navigation team works to maximize coverage and reportedly accepts most major commercial plans
  • ✓Money-back guarantee tied to a 10% weight-loss outcome over the program year
  • ✓Publishes 3-year outcomes data (19% mean weight loss)

Cons

  • ✗Medication cost is on top of the $199/month fee; cash-pay patients face full manufacturer pricing
  • ✗Insurance navigation only helps if your plan actually covers branded GLP-1s for weight loss — many don't
  • ✗Meaningfully more expensive than compounded telehealth if your insurance denies coverage
  • ✗Distinct from 'Oxford's Medical Weight Loss (The Calibrate Clinic)' — don't confuse the two
  • ✗Initial 3-month commitment ($597 total, billed as $199/mo) before it renews monthly — more lock-in than month-to-month rivals
Starting from $25/moRead full review →
Visit Calibrate Health →

How to choose an oral GLP-1 provider

Oral GLP-1s — orforglipron (Foundayo) and oral semaglutide (Rybelsus / oral Wegovy) — trade some effectiveness for needle-free convenience. The key is getting an FDA-approved pill from a legitimate prescriber, not an OTC 'GLP-1 pill' with no evidence.

What to look for

  • FDA-approved pill, not a supplement. Only orforglipron and oral semaglutide are real oral GLP-1 medications. 'GLP-1 support' supplements sold over the counter are not GLP-1 drugs — make sure you're getting the prescription product.
  • Know the dosing rules. Oral semaglutide must be taken on an empty stomach with strict water timing; orforglipron has no food restrictions. Pick the one that fits your routine, and confirm the provider explains the protocol.
  • Pill vs. injection honesty. A good provider will tell you injections generally produce more weight loss. If a pill is being oversold as equal to or better than injectables, be skeptical.

Red flags to avoid

  • No named pharmacy or LegitScript listing. A legitimate compounded-GLP-1 provider names its 503A/503B pharmacy partner and carries LegitScript certification. If neither is disclosed, you can't verify what you're injecting.
  • Async-only, no real clinician review. A prescriber should review your intake and be reachable for dose questions. Instant approval with no way to reach a clinician is a safety gap.
  • Teaser pricing that hides the real cost. A low 'first month' price that jumps at higher doses, or a membership fee stacked on top of the medication, can double the true monthly total. Confirm the ongoing, all-in price before you pay.
  • Weight-loss claims for B12, MIC, or HCG shots. Only GLP-1 injections have trial evidence for weight loss. A clinic selling B12, lipotropic, or HCG shots as a weight-loss treatment is a red flag.

Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.

How we rank & what counts as “legit”

Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.

Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].

Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].

Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Frequently Asked Questions

Yes, with caveats. FDA-approved oral GLP-1s — orforglipron (Foundayo) and oral semaglutide (Rybelsus / oral Wegovy) — produce real, trial-backed weight loss, though generally less than the top injectable, tirzepatide. Over-the-counter 'GLP-1 pills' and supplements are not GLP-1 medications and don't have comparable evidence.
For weight loss, orforglipron (Foundayo) is the newest and most convenient — a once-daily pill with no food-timing rules — while oral semaglutide (oral Wegovy) is also FDA-approved but must be taken on an empty stomach with strict water timing. Both require a prescription; the providers above prescribe them online.
Injections (semaglutide, tirzepatide) currently produce more weight loss on average, but they're weekly shots. Pills trade some efficacy for needle-free, daily convenience and can be easier to start. If effectiveness is the priority, an injection usually wins; if needle avoidance or simplicity matters more, an oral GLP-1 is a legitimate option.
Each provider is evaluated across six weighted dimensions: Value (25%), Effectiveness (25%), User Experience (15%), Trust & Safety (15%), Accessibility (10%), and Support (10%). We research publicly available information, user reviews, clinical evidence, and pricing data, then compute a weighted overall score out of 10.
Each provider's score is computed independently using the six-dimension methodology, and a commercial relationship never changes a provider's underlying score — you can see every provider's full score on its card. Some providers have affiliate agreements with us, meaning we earn a commission if you click through and make a purchase. On our highest-commercial-intent lists — including the semaglutide, tirzepatide, compounded and cheapest molecule lists, the weight-loss injection and shot lists, and the fitness-app list — we feature affiliate partners in the top positions; on every other list the order follows the score (or, for the cheapest lists, the lowest price) directly. This placement is disclosed here and on our methodology and affiliate-disclosure pages.
Sources & methodology — as of October 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  5. 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  8. 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
  9. 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  10. 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
  11. 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.

Related Rankings